Literature DB >> 9199414

The tumor necrosis factor alpha-stimulating region of galactose-inhibitable lectin of Entamoeba histolytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide.

R Séguin1, B J Mann, K Keller, K Chadee.   

Abstract

Entamoeba histolytica adheres via galactose-lectin (Gal-lectin) to human colonic mucins and intestinal epithelial cells as a prerequisite to amebic invasion. Native Gal-lectin is a protective antigen in the gerbil model of amebiasis. Amino acids 596 to 1082 of Gal-lectin mediate E. histolytica adherence to target cells and stimulate tumor necrosis factor alpha (TNF-alpha) production by naive murine bone marrow macrophages (BMM). Resistance to amebiasis requires an effective cell-mediated immune response against E. histolytica trophozoites mediated by nitric oxide (NO) released from activated macrophages. Herein, we determine whether the TNF-alpha-stimulating region of Gal-lectin can activate gamma interferon (IFN-gamma)-primed BMM for NO production and amebicidal activity. Native Gal-lectin (100 to 500 ng/ml) stimulated TNF-alpha and inducible nitric oxide synthase (iNOS) mRNA expression in IFN-gamma-primed BMM as did lipopolysaccharide (100 ng/ml). Primed BMM produced TNF-alpha and NO in response to Gal-lectin in a dose-dependent manner. Antilectin monoclonal antibody IG7, which recognizes a domain (amino acids 596 to 818) of the TNF-alpha mRNA-stimulating region of Gal-lectin, specifically inhibited TNF-alpha and iNOS mRNA induction and TNF-alpha and NO production by primed BMM in response to Gal-lectin (100 ng/ml). Simultaneous treatment of BMM with IFN-gamma and Gal-lectin (100 ng/ml) activated the cells to kill E. histolytica trophozoites, whereas IFN-gamma treatment alone had no effect. In the presence of monoclonal antibody 1G7 or aminoguanidine (an iNOS inhibitor), NO production and amebicidal activity were inhibited >80%. These results suggest that the TNF-alpha-stimulating region of native Gal-lectin is a potent stimulus of IFN-gamma-primed BMM for NO production, which is essential for host defense against amebiasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199414      PMCID: PMC175356          DOI: 10.1128/iai.65.7.2522-2527.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Immunopathology of Entamoeba histolytica infections.

Authors:  M Denis; K Chadee
Journal:  Parasitol Today       Date:  1988-09

2.  Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit.

Authors:  B J Mann; C Y Chung; J M Dodson; L S Ashley; L L Braga; T L Snodgrass
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

3.  In vitro and in vivo studies of macrophage functions in amebiasis.

Authors:  M Denis; K Chadee
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

4.  Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection.

Authors:  W Wang; K Keller; K Chadee
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

5.  Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites.

Authors:  M Denis; K Chadee
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

6.  Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages.

Authors:  W Deng; B Thiel; C S Tannenbaum; T A Hamilton; D J Stuehr
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

7.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

8.  Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes.

Authors:  J I Ravdin; R L Guerrant
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide.

Authors:  R B Lorsbach; W J Murphy; C J Lowenstein; S H Snyder; S W Russell
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

10.  Entamoeba histolytica suppresses gamma interferon-induced macrophage class II major histocompatibility complex Ia molecule and I-A beta mRNA expression by a prostaglandin E2-dependent mechanism.

Authors:  W Wang; K Chadee
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more
  24 in total

Review 1.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine.

Authors:  Xiaoti Guo; Lisa Barroso; David M Lyerly; William A Petri; Eric R Houpt
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

3.  CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils.

Authors:  Catherine P A Ivory; Kathy Keller; Kris Chadee
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon.

Authors:  Xiaoti Guo; Lisa Barroso; Steven M Becker; David M Lyerly; Thomas S Vedvick; Steven G Reed; William A Petri; Eric R Houpt
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

5.  Association between TNF-alpha and Entamoeba histolytica diarrhea.

Authors:  Kristine M Peterson; Jianfen Shu; Priya Duggal; Rashidul Haque; Dinesh Mondal; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

6.  Gal-lectin-dependent contact activates the inflammasome by invasive Entamoeba histolytica.

Authors:  L Mortimer; F Moreau; S Cornick; K Chadee
Journal:  Mucosal Immunol       Date:  2013-11-20       Impact factor: 7.313

7.  Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA.

Authors:  Catherine P A Ivory; Michael Prystajecky; Christian Jobin; Kris Chadee
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

Review 8.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

Review 9.  Host-microbe interactions and defense mechanisms in the development of amoebic liver abscesses.

Authors:  Julien Santi-Rocca; Marie-Christine Rigothier; Nancy Guillén
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults.

Authors:  Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Mary A Misukonis; Jocelyn R Saunders; Sri Suprianto; J Brice Weinberg; Nicholas M Anstey
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.